Corsodyl Aniseed 0.2% w/v Mouthwash

  • Name:

    Corsodyl Aniseed 0.2% w/v Mouthwash

  • Company:
    info
  • Active Ingredients:

    Chlorhexidine digluconate

  • Legal Category:

    Supply through general sale

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 09/08/19

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 26/9/2019

Click on this link to Download PDF directly

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name Andrews Liver Salts Effervescent Powder Active Ingredients Citric Acid (Anhydrous), Magnesium sulfate (dihydrate), Sodium Hydrogen Carbonate
Medicine Name Corsodyl Aniseed 0.2% w/v Mouthwash Active Ingredients Chlorhexidine digluconate
Medicine Name Corsodyl 1% w/w Dental Gel Active Ingredients Chlorhexidine digluconate
Medicine Name Corsodyl Mint 0.2% w/v Mouthwash Active Ingredients Chlorhexidine digluconate
Medicine Name Day Nurse Capsules Active Ingredients Paracetamol, Pholcodine, Pseudoephedrine Hydrochloride
Medicine Name Duofilm Cutaneous Solution Active Ingredients Lactic Acid, Salicylic Acid
Medicine Name Eurax 10% w/w Cream Active Ingredients Crotamiton
Medicine Name Excedrin 250 mg /250 mg /65 mg film-coated tablets Active Ingredients Aspirin, Caffeine, Paracetamol
Medicine Name Flixonase Allergy Relief Nasal Spray Active Ingredients Fluticasone Propionate
Medicine Name Lamisil 1% w/w Cream Active Ingredients Terbinafine hydrochloride
Medicine Name Lamisil AT Cream Active Ingredients Terbinafine hydrochloride
Medicine Name Lamisil Once 1% cutaneous solution Active Ingredients Terbinafine hydrochloride
Medicine Name Nicotinell Cool Mint 2mg medicated chewing gum Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Cool Mint 4mg medicated chewing gum Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Fruit 2mg medicated chewing-gums Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Fruit 4mg Medicated Chewing-Gums Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Mint 1mg Compressed Lozenges Active Ingredients nicotine bitartrate dihydrate
Medicine Name Nicotinell Mint 2mg compressed Lozenges Active Ingredients nicotine bitartrate dihydrate
Medicine Name Nicotinell TTS 10, 7 mg/24 hour Transdermal Patch Active Ingredients Nicotine
Medicine Name Nicotinell TTS 20, 14 mg/24 hour Transdermal Patch Active Ingredients Nicotine
Medicine Name Nicotinell TTS 30, 21 mg/24 hour Transdermal Patch Active Ingredients Nicotine
Medicine Name Night Nurse Capsules Active Ingredients Dextromethorphan Hydrobromide, Paracetamol, Promethazine hydrochloride
Medicine Name Night Nurse Cold Remedy Active Ingredients Dextromethorphan Hydrobromide, Paracetamol, Promethazine hydrochloride
Medicine Name Oilatum Cream Active Ingredients Light Liquid Paraffin, White Soft Paraffin
Medicine Name Oilatum Emollient 63.4% w/w Bath Additive Active Ingredients Light Liquid Paraffin
1 - 0 of 52 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 26 September 2019 SmPC

Reasons for updating

  • Change to product name

Legal category: Supply through general sale

Updated on 9 August 2019 PIL

Reasons for updating

  • Change to name of medicinal product
  • Improved presentation of PIL
  • Change to packaging

Updated on 8 August 2019 SmPC

Reasons for updating

  • Change to section 1 - Name of medicinal product

Legal category: Supply through general sale

Updated on 28 April 2016 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Supply through general sale

Updated on 28 April 2016 SmPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.3 - Preclinical safety data

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

A Type II variation (category C.I.4) submitted to align the product SmPC to GSK Global Data Sheet

Updated on 27 April 2016 PIL

Reasons for updating

  • New PIL for new product

Updated on 27 April 2016 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications

Updated on 10 July 2015 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 7

Marketing Authorisation Holder address updated to:

12 Riverwalk,

Citywest Business Campus,

Dublin 24,

Ireland

Updated on 25 November 2014 SmPC

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.4 Inclusion of excipient warnings for macrogolglycerol hydroxystearate and azo dye Ponceau 4R
Section 4.8 Addition of information regarding the reporting of suspected adverse reactions

Updated on 21 November 2014 PIL

Reasons for updating

  • Change to side-effects

Updated on 11 March 2014 PIL

Reasons for updating

  • Change to warnings or special precautions for use

Updated on 25 February 2014 PIL

Reasons for updating

  • Change due to user-testing of patient information

Updated on 22 October 2010 SmPC

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.4 - Special precautions for storage
  • Change to section 10 - Date of revision of the text

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 2 (Qualitative and Quantitative was updated to read as follows:
"Chlorhexidine Digluconate 0.2% w/v
(as Chlorhexidine Digluconate Solution)
 Excipients: Contains Macrogolglycerol hydroxystearate 0.8% w/v
For a full list of excipients, see section .6.1"

Section 6.4 (special precautions for storage): the following was added:"Store in the original container in order to protect from light."

In Section 10 (date of revision of the text) the date was changed to september 2010


Updated on 13 August 2010 PIL

Reasons for updating

  • Change of manufacturer
  • Change to date of revision

Updated on 12 April 2010 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 10

date of text revision is corrected

Updated on 21 July 2009 SmPC

Reasons for updating

  • Change to section 6.1 - List of excipients

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 6.1 - replacement of excipient with a comparable excipient

Updated on 15 July 2009 SmPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 10 - Date of revision of the text

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.2 - Children under 12 warning added
Section 4.4 - Addition of warning re irritation and discoloration
Section 4.8 - Additional warning re tingling and numbness 
Section 4.9 - Addition of alcohol warning for children

Updated on 18 August 2008 SmPC

Reasons for updating

  • Change to section 4.8 - Undesirable effects
  • Change to section 6.1 - List of excipients
  • Change to section 10 - Date of revision of the text

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

4.8 Undesirable effects

Irritative skin reactions

Irritative skin reactions to chlorhexidine preparations can occasionally occur. Generalised allergic reactions to chlorhexidine have been reported but are extremely rare.
 

Generalised reactions

Allergic reactions, hypersensitivity & anaphylaxis to chlorhexidine have also been reported but are extremely rare.

 

 

6.1 List of excipients

Ethanol (96%)

Macrogolglycerol Hydroxystearate Ph. Eur.

Anise Oil

Peppermint Oil

Ponceau 4R (E124)

Purified water.

 

 

10 Date of revision of the text

February 2008

Updated on 27 March 2008 SmPC

Reasons for updating

  • Change to section 4.8 - Undesirable effects

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.8  Undesirable Effects
 
The last sentence of section 4.8 of the SPC, which begins with "Generalised allergic reactions" should be deleted and a new heading should be added, so that the end of section 4.8 reads as follows:
Irritative skin reactions
 
Irritative skin reactions to chlorhexidine preparations can occasionally occur.
 
Generalised reactions

Allergic reactions, hypersensitivity & anaphylaxis to chlorhexidine have also been reported but are extremely rare.

 

Updated on 30 November 2007 SmPC

Reasons for updating

  • Change to section 4.1 - Therapeutic indications

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

SECTION 4.1
"Also for use in a post-periodontal surgery or treatment regimen to promote gingival healing."

Updated on 15 October 2007 PIL

Reasons for updating

  • New PIL for medicines.ie

Updated on 27 October 2006 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

10. Date of Revision of the Text

                            March 2006

Updated on 23 March 2006 SmPC

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 4.8 - Undesirable effects
  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 9 - Date of renewal of authorisation

Legal category: Supply through general sale

Updated on 1 July 2003 SmPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Supply through general sale